* Therapeutic area
Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive access to available contract documents for over 600 co-promotion and co-marketing deals. Analyzing actual contract agreements allows assessment of the following:
* What are the precise co-promotion and co-marketing rights granted or optioned?
* What is actually granted by the agreement to the partner company?
* What exclusivity is granted?
* What is the payment structure for the deal?
* How are sales and payments audited?
* What is the deal term?
* How are the key terms of the agreement defined?
* How are IPRs handled and owned?
* Who is responsible for commercialization?
* Who is responsible for development, supply, and manufacture?
* How is confidentiality and publication managed?
* How are disputes to be resolved?
* Under what conditions can the deal be terminated?
* What happens when there is a change of ownership?
* What sublicensing and subcontracting provisions have been agreed?
* Which boilerplate clauses does the company insist upon?
* Which boilerplate clauses appear to differ from partner to partner or deal
Table of ContentsNumber of pages: 387Executive SummaryChapter 1 - IntroductionChapter 2 - Trends in co-promotion and co-marketing dealmaking* 2.1. Introduction
* 2.2. Difference between co-promotion and co-marketing deals
* 2.3. Trends in co-promotion deals since 2000
* 2.4. Trends in co-marketing deals since 2000
* 2.4.1. When co-marketing can be useful
* 2.4.2. When co-marketing is the only option
* 2.5. Pure deals and multi-component deals
Copyright©2010 PR Newswire.
All rights reserved